Related Experiment Video
Updated: Oct 18, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral Center
Magdalena Hoellwerth1, Andreas Kaiser2, Michael Emberger3
1Department of Dermatology and Allergology, Paracelsus Medical University, 5020 Salzburg, Austria.
Abstract:
The collateral damage caused by COVID-19 pandemic-associated public health and governmental measures on patient care has been increasingly assessed in various oncological and non-oncological clinical settings. In order to investigate potential adverse effects in the field of melanoma the present study analyzed the characteristics of primary melanoma diagnoses at an Austrian dermato-pathological referral center before, during, and after the first coronavirus-related lockdown in March 2020. As suspected, we found significant temporary reductions in the number of newly diagnosed melanomas in 2020 compared to previous years, in particular, during the first lockdown period.
Insights
The COVID-19 pandemic and associated public health measures led to a significant decrease in new melanoma diagnoses in 2020. This reduction was most pronounced during the initial lockdown period, impacting patient care.
Area of Science:
- Dermatology and Public Health
Background:
- The COVID-19 pandemic prompted public health and governmental measures impacting healthcare delivery.
- Assessing collateral damage on patient care in oncological and non-oncological settings is crucial.
Purpose of the Study:
- To investigate the impact of the COVID-19 pandemic on primary melanoma diagnoses.
- To analyze changes in melanoma diagnosis characteristics during and after the first lockdown in Austria.
Main Methods:
- Retrospective analysis of primary melanoma diagnoses.
- Data collected from an Austrian dermato-pathological referral center.
- Comparison of diagnoses before, during, and after the March 2020 lockdown.
Main Results:
- A significant temporary reduction in newly diagnosed melanomas was observed in 2020.
- The most substantial decrease occurred during the initial COVID-19 lockdown period.
- Findings confirm suspected adverse effects on melanoma diagnosis rates.
Conclusions:
- The COVID-19 pandemic lockdown temporarily reduced melanoma diagnoses.
- Healthcare disruptions during the pandemic affected early cancer detection.
- Further research is needed to understand long-term consequences for melanoma patient care.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

